Morgan Stanley ALNYLAM PHARMACEUTICALS INC Transaction History

Morgan Stanley

  • $1.49 Trillion
  • Q2 2025
Number of Shares
11,028,000
Previous 9,975,000 10.56%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 15, 2025
BUY
N/A
1,053,000 Added 10.56%
11,028,000 $0
Q1 2025

May 15, 2025
SELL
N/A
-1,378,000 Reduced 12.14%
9,975,000 $0
Q4 2024

Feb 14, 2025
SELL
N/A
-3,310,000 Reduced 22.57%
11,353,000 $0
Q3 2024

May 14, 2025
SELL
N/A
-1,090,000 Reduced 6.92%
14,663,000 $0
Q3 2024

Nov 14, 2024
SELL
N/A
-1,090,000 Reduced 6.92%
14,663,000 $0
Q2 2024

May 14, 2025
BUY
N/A
4,400,000 Added 38.76%
15,753,000 $0
Q2 2024

Oct 17, 2024
BUY
N/A
5,783,000 Added 58.0%
15,753,000 $0
Q2 2024

Aug 14, 2024
BUY
N/A
5,783,000 Added 58.0%
15,753,000 $0
Q1 2024

Oct 17, 2024
SELL
N/A
-5,783,000 Reduced 36.71%
9,970,000 $0
Q1 2024

Aug 16, 2024
BUY
N/A
810,000 Added 8.84%
9,970,000 $0
Q1 2024

May 15, 2024
BUY
N/A
810,000 Added 8.84%
9,970,000 $0
Q4 2023

Aug 16, 2024
SELL
N/A
-6,593,000 Reduced 41.85%
9,160,000 $0
Q4 2023

Feb 13, 2024
SELL
N/A
-1,562,000 Reduced 14.57%
9,160,000 $0
Q3 2023

Nov 15, 2023
BUY
N/A
10,722,000 New
10,722,000 $0
Track This Portfolio

Track Morgan Stanley Portfolio

Follow Morgan Stanley and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email